Which parameter is specific between normal cognitive function and declined cognitive function in diabetes patients?

Investigation of a high-risk group that should be considered for cognitive function testing in diabetes treatment - Investigation of a high-risk group that should be considered for cognitive function testing in diabetes treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038439

Enrollment

200

Registered

2019-11-01

Start date

2016-07-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inpatients diagnosed with diabetes mellitus, who were admitted to the Department of Diabetes and Metabolic Diseases at The University of Tokyo Hospital between 17/07/2016 and 31/03/2017

Exclusion criteria

Exclusion criteria: 1.Pregnant 2.Lactating 3.Acute organ failure (e.g., pneumonia, acute myocardial infarction, acute cerebral infarction, diabetic ketoacidosis, and hyperosmolar hyperglycemic state) 4.Congenital cognitive disorders

Design outcomes

Primary

Measure	Time frame
Cognitive dysfunction is measured using the Mini Mental State Examination (MMSE) score after getting consent.	—

Countries

Japan

Contacts

Public ContactYuka Kobayashi

University of Tokyo Hospital Department of Diabetes and Metabolic Diseases

kobayashiyu-int@h.u-tokyo.ac.jp0358008815

Outcome results